Coactivator PC4 mediates AP-2 transcriptional activity and suppresses ras-induced transformation dependent on AP-2 transcriptional interference

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 899-908

  Kannan, Perry ^a   Tainsky, Michael A ^b,c  

^a METROHEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL TRANSFORMATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE RAS; PRIORITY JOURNAL;

EID: 0032954206     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.1.899     Document Type: Article

References (36)

1. Bohm, M., H. Kirch, T. Otto, H. Rubben, and I. Wieland. 1997. Deletion analysis at the DEL-27, APC and MTSI loci in bladder cancer: LOH at the DEL-27 locus on 5p13-12 is a prognostic marker of tumor progression. Int. J. Cancer 74:291-295.
2. Bosher, J. M., T. Williams, and H. C. Hurst. 1995. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. USA 92:744-747.
3. Buettner, R., P. Kannan, A. Imhof, R. Bauer, S. O. Yim, R. Glockshuber, M. W. Van Dyke, and M. A. Tainsky. 1993. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol. Cell. Biol. 13:4174-4185.
4. Chiang, C. M., H. Ge, Z. Wang, A. Hoffmann, and R. G. Roeder. 1993. Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III. EMBO J. 12:2749-2762.
5. Chiu, R., M. Imagawa, R. J. Imbra, J. R. Bockoven, and M. Karin. 1987. Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature 329:648-651.
6. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in u soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
7. Flanagan, P. M., R. J. D. Kelleher, M. H. Sayre, H. Tschochner, and R. D. A. Kornberg. 1983. Mediator required for activation of RNA polymerase II transcription in vitro. Nature 350:436-438.
8. Ge, H., and R. G. Roeder. 1994. Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell 78:513-523.
9. Ge, H., Y. Zhao, B. T. Chait, and R. G. Roeder. 1994. Phosphorylation negatively regulates the function of coactivator PC4. Proc. Natl. Acad. Sci. USA 91:12691-12695.
10. Gill, G., and M. Ptashne. 1988. Negative effect of the transcriptional activator GAL4. Nature 334:721-724.
11. Hollywood, D. P., and H. C. Hurst. 1993. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J. 12:2369-2375.
12. Hyman, S. E., M. Comb, J. Pearlberg, and H. M. Goodman. 1989. An AP-2 element acts synergistically with the cyclic AMP- and phorbol ester-inducible enhancer of the human proenkephalin gene. Mol. Cell. Biol. 9:321-324.
13. Imagawa, M., R. Chiu, and M. Karin. 1987. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51:251-260.
14. Kaiser, K., G. Stelzer, and M. Meisterernst. 1995. The coactivator p15 (PC4) initiates transcriptional activation during TFIIA-TFIID-promoter complex formation. EMBO J. 14:3520-3527.
15. Kannan, P., R. Buettner, P. J. Chiao, S. O. Yim, M. Sarkiss, and M. A. Tainsky. 1994. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev. 8:1258-1269.
16. Kannan, P., and M. A. Tainsky. Unpublished data.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
18. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
19. Luscher, B., P. J. Mitchell, T. Williams, and R. Tjian. 1989. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev. 3:1507-1517.
20. Malik, S., M. Guennah, and R. G. Roeder. 1998. A dynamic model for PC4 coactivator function in RNA polymerase II transcription. Proc. Natl. Acad. Sci. USA 95:2192-2197.
21. McPherson, L. A., V. R. Baichwal, and R. J. Weigel. 1997. Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. Natl. Acad. Sci. USA 94:4342-4347.
22. Meyer, M. E., H. Gronemeyer, B. Turcotte, M. T. Bocquel, D. Tasset, and P. Chambon. 1989. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433-442.
23. Mitchell, P. J., P. M. Timmons, J. M. Hebert, P. W. Rigby, and R. Tjian. 1991. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5:105-119.
24. Prywes, R., and H. Zhu. 1992. In vitro squelching of activated transcription by serum response factor: evidence for a common coactivator used by multiple transcriptional activators. Nucleic Acids Res. 20:513-520.
25. Ptashne, M. 1988. How eukaryotic transcriptional activators work. Nature 335:683-689.
26. Sadowski, I., J. Ma, S. Triezenberg, and M. Ptashne. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564.
27. Sawardogo, M., and R. G. Roeder. 1985. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 43:165-175.
28. Smith, D. B., and M. L. Concoran. 1991. Unit 16-7, p. 1-8. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidmen, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Green Publishing Associates and Wiley Interscience, New York, N.Y.
29. Tainsky, M. A., D. B. Krizman, P. J. Chiao, S. O. Yim, and B. C. Giovanella. 1988. PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors. Anticancer Res. 8:899-913.
30. Tainsky, M. A., C. S. Cooper, B. C. Giovanella, and G. F. Vande Woude. 1984. An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells. Science 225:643-645.
31. Wang, J. C., and M. W. Van Dyke. 1994. Sp1, USF, and GAL4 activate transcription independently of TFIID-downstream promoter interactions. Biochim. Biophys. Acta 1218:308-314.
32. Wieland, I., M. Bohm, K. C. Arden, T. Ammermuller, S. Bogatz, C. S. Viars, and M. F. Rajewsky. 1996. Allelic deletion mapping on chromosome 5 in human carcinomas. Oncogene 12:97-102.
33. Williams, T., A. Admon, B. Luscher, and R. Tjian. 1988. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2:1557-1569.
34. Williams, T., and R. Tjian. 1991. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev. 5:670-682.
35. Zeuthen, J., J. D. R. Norgaard, P. Avner, M. Fellows, J. Wartiovaara, A. Vaheri, J. Rosen, and B. C. Giovanella. 1980. Characterization of a human ovarian teratocarcinoma-derived cell line. Int. J. Cancer 25:19-32.
36. Zhu, H., V. Joliot, and R. Prywes. 1994. Role of transcription factor TFIIF in serum response factor-activated transcription. J. Biol. Chem. 269:3489-3497.